Azenosertib Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: C29H34N8O2, KP-2638, ZN-c3, Zn-c3

Filter by location:

Mobile, Alabama1 trial

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Site 0170-USA Mitchell Cancer Institute

Phase 2

Boston, Massachusetts1 trial

Azenosertib in Uterine Serous Carcinoma: Biomarker Study

Brigham and Women's Hospital

Phase 2

Portland, Oregon1 trial

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

OHSU Knight Cancer Institute

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.